https://www.avient.com/sites/default/files/2021-04/avient-q4-earnings-and-2021-outlook-website.pdf
acquisition • Cash flow deployed to M&A, opportunistic share repurchases and balance
sheet / leverage reduction 3.5x 2.7x 2.1x 2019PF 2020PF 2021E Net Debt / Adjusted
https://www.avient.com/sites/default/files/2021-04/avnt-fourth-quarter-2020-news-release.pdf
valuation allowances. 8 Attachment 4 Avient Corporation Condensed Consolidated Balance
Sheets (Unaudited) (In millions) Year Ended December 31, 2020 2019 ASSETS Current
https://www.avient.com/sites/default/files/2020-10/investing-in-avient.pdf
per Company filings, resulting in a cash adjustment from the June 30, 2020 balance
sheet of ~$1,520MM 2.
https://www.avient.com/sites/default/files/2024-08/AVNT Second Quarter Earnings Press Release.pdf
valuation allowances. 10 Attachment 4 Avient Corporation Condensed Consolidated Balance
Sheets (In millions) (Unaudited) June 30, 2024 December 31, 2023 ASSETS Current
https://www.avient.com/sites/default/files/2023-11/AVNT Q3 2023 Earnings Press Release.pdf
valuation allowances. 10 Attachment 4 Avient Corporation Condensed Consolidated Balance
Sheets (In millions) (Unaudited) September 30, 2023 December 31, 2022 ASSETS
https://www.avient.com/sites/default/files/2023-07/AVNT Q2 2023 Earnings Press Release%5B43%5D.pdf
valuation allowances. 10 Attachment 4 Avient Corporation Condensed Consolidated Balance
Sheets (In millions) (Unaudited) June 30, 2023 December 31, 2022 ASSETS Current
https://www.avient.com/sites/default/files/2021-03/avient-march-ir-fermium_0.pdf
acquisition • Cash flow deployed to M&A, opportunistic share repurchases and balance
sheet / leverage reduction 3.5x 2.7x 2.1x 2019PF 2020PF 2021E Net Debt / Adjusted
https://www.avient.com/sites/default/files/2023-02/AVNT Q4 2022 Earnings Presentation.pdf
EBITDA $845 $3,450 Q1 FY Adjusted EPS (in millions) (in millions) CASH FLOW / BALANCE
SHEET 21 • IT investment to further integrate acquired businesses and capture
https://www.avient.com/sites/default/files/2023-03/AVNT Mar 2023 Earnings Presentation.pdf
EBITDA $845 $3,450 Q1 FY Adjusted EPS (in millions) (in millions) CASH FLOW / BALANCE
SHEET 25 • IT investment to further integrate acquired businesses and capture
https://www.avient.com/industries/healthcare/medical-devices-equipment/surgical-medical-instruments
Developing surgical tools and accessories is a delicate balance of functionality